Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Nesvacumab (REGN910/ SAR307746)

This study has been completed.
Information provided by (Responsible Party):
Regeneron Pharmaceuticals Identifier:
First received: January 5, 2011
Last updated: June 12, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2015
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)